Showing 1 – 9 of 9 results.
Curated
Anticipating Community Drug Problems in Washington, DC, and Portland, Oregon, 1984-1990 (ICPSR 9924)
Released/updated on: 1994-02-17
Geographic coverage: Oregon, District of Columbia, United States, Portland (Oregon)
Time period: 1984-01-01--1990-01-01
This study examined the use of arrestee urinalysis results as a predictor of other community drug problems. A three-stage public health model was developed using drug diffusion and community drug indicators as aggregate measures of individual drug use careers. Monthly data on drug indicators for Washington, DC, and Portland, Oregon, were used to: (1) estimate the correlations of drug problem indicators over time, (2) examine the correlations among indicators at different stages in the spread of new forms of drug abuse, and (3) estimate lagged models in which arrestee urinalysis results were used to predict subsequent community drug problems. Variables included arrestee drug test results, drug-overdose deaths, crimes reported to the local police department, and child maltreatment incidents. Washington variables also included drug-related emergency room episodes. The unit of analysis was months covered by the study. The Washington, DC, data consist of 78 records, one for each month from April 1984 through September 1990. The Portland, Oregon, data contain 33 records, one for each month from January 1988 through September 1990.
Curated
Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): National Criminal Justice Treatment Program (NCJTP) Survey in the United States, 2002-2008 (ICPSR 27382)
Released/updated on: 2010-08-09
Geographic coverage: District of Columbia, United States
Time period: 2002-01-01--2008-01-01
The National Criminal Justice Treatment Practices (NCJTP) Survey provides a comprehensive inquiry into the nature of programs and services provided to adult and juvenile offenders involved in the justice system in the United States. Participants included key criminal justice administrators, operations managers, and staff. This survey was conducted in all 50 states and the District of Columbia. The survey involved a myriad of state, regional, and local organizations employing a mix of their own staff and contracted personnel, and services that might involve multiple levels of government. It was a self-administrated, paper-and-pencil questionnaire. The methodology included a multilevel approach that captured the perspective of executives, front-line administrators, and line staff about current practices in a range of institutional and community correctional settings for adults and juveniles. The goals for this survey were: to describe current drug treatment practices, policies, and delivery systems for offenders on probation or parole supervision, and in jails, prisons, and youth institutions; to examine agency structures, resources, and other organizational factors that may affect service delivery, including mission, leadership, climate, culture, and beliefs about rehabilitation versus punishment; and to assess coordination and integration across criminal justice agencies and between corrections and treatment systems. Items in the survey included: respondent characteristics, organizational characteristics, correctional programs characteristics (e.g., size, nature, etc.), substance abuse treatment programs characteristics, social networks/agencies collaboration, integration of services with other agencies, attitudes toward punishment and rehabilitation (personal values), organizational needs assessment, organizational culture and climate for treatment, cynicism toward change, organizational commitment to treatment, and perspectives on intradepartmental coordination.
Curated
Cuyahoga County, Ohio, Heroin and Crime Initiative: Informing the Investigation and Prosecution of Heroin-Related Overdose, 2012-2021 (ICPSR 38295)
Released/updated on: 2023-09-27
Geographic coverage: United States, Ohio
Time period: 2012-01-01--2020-01-01, 2014-01-01--2019-01-01, 2018-04-01--2021-09-30
In 2013, the Cuyahoga County (Ohio) Medical Examiner's Office (CCMEO) and the Regional Forensic Science Laboratory developed the Heroin Involved Death Investigation (HIDI) alert system and protocol in response to a substantial increase in opioid-related overdose fatalities. The HIDI protocol is designed to support a safe, coordinated, and rapid response to an active, suspected opioid-overdose death scene, or suspected opioid-overdose deaths occurring at hospitals that are not considered active scenes, by alerting investigators to potential dangers and facilitating the timely protection of scene integrity and evidence collection in order to successfully investigate and prosecute drug traffickers.
The primary goals of the project were to:
- Complete extended coding of local medical examiner decedent data--investigative reports and toxicology to identify demographic or geographic trends or patterns of overdose deaths, as well as paraphernalia and evidence present at death scenes that may be useful to prosecutions;
- Examine the efficiency of how cases flow through the investigative and prosecutorial stages and how these could be improved;
- Identify key variables that may contribute to the successful indictment of traffickers connected to fatal and non-fatal overdose cases; and
- Evaluate the implementation and perceived effectiveness of the Cuyahoga County HIDI protocol.
This multi-method project involved three phases of data collection and analysis. First, a forensic epidemiologist coded and analyzed existing CCMEO records for decedent toxicology and death scene characteristics, focusing on drug-related fatalities. Second, county and federal cases prosecuted for drug trafficking, especially those linked to deaths, were systematically reviewed to determine what evidence was deemed important for successful indictment. Third, interviews and focus groups were conducted with key stakeholders from local and federal law enforcement, intelligence analysts, public health officials, and local and federal prosecutors to learn about the HIDI protocol.
Data and documentation for interviews and focus groups will be made available in a future update.
Curated
Simple Crosstabs
Delaware Opioid Metric Intelligence Project (DOMIP), 2013-2020 (ICPSR 38317)
Released/updated on: 2022-09-14
Geographic coverage: United States, Delaware
Time period: 2013-01-01--2020-01-01
The Delaware Opioid Metric Intelligence Project (DOMIP) provides community surveillance capabilities in Delaware to help reduce its prescription and illicit drug problems. DOMIP achieves this by integrating data on overdose deaths, crime, population characteristics and community resources into a user-friendly web application called the DOMIP Mapping app.
Curated
Drug Abuse Warning Network (DAWN), 1994: [United States] (ICPSR 2756)
Released/updated on: 2014-08-13
Geographic coverage: United States
The Drug Abuse Warning Network (DAWN) survey is designed to capture data on emergency department (ED) episodes that are induced by or related to the use of an illicit, prescription, or over-the-counter drug. For purposes of this collection, a drug "episode" is an ED visit that was induced by or related to the use of an illegal drug or the nonmedical use of a legal drug for patients aged six years and older. A drug "mention" refers to a substance that was mentioned during a drug-related ED episode. Because up to four drugs can be reported for each drug abuse episode, there are more mentions than episodes in the data. Individual persons may also be included more than once in the data. Within each facility participating in DAWN, a designated reporter, usually a member of the emergency department or medical records staff, was responsible for identifying drug-related episodes and recording and submitting data on each case. An episode report was submitted for each patient visiting a DAWN emergency department whose presenting problem(s) was/were related to their own drug use. DAWN produces estimates of drug-related emergency department visits for 50 specific drugs, drug categories, or combinations of drugs, including the following: acetaminophen, alcohol in combination with other drugs, alprazolam, amitriptyline, amphetamines, aspirin, cocaine, codeine, diazepam, diphenhydramine, fluoxetine, heroin/morphine, inhalants/solvents/aerosols, LSD, lorazepam, marijuana/hashish, methadone, methamphetamine, and PCP/PCP in combination with other drugs. The use of alcohol alone is not reported. The route of administration and form of drug used (e.g., powder, tablet, liquid) are included for each drug. Data collected for DAWN also include drug use motive and total drug mentions in the episode, as well as race, age, patient disposition, reason for ED visit, and day of the week, quarter, and year of episode.
Curated
Drug Abuse Warning Network (DAWN), 1997: [United States] (ICPSR 2834)
Released/updated on: 2014-08-13
Geographic coverage: United States
The Drug Abuse Warning Network (DAWN) survey is designed to capture data on emergency department (ED) episodes that are induced by or related to the use of an illicit, prescription, or over-the-counter drug. For purposes of this collection, a drug "episode" is an ED visit that was induced by or related to the use of an illegal drug or the nonmedical use of a legal drug for patients aged six years and older. A drug "mention" refers to a substance that was mentioned during a drug-related ED episode. Because up to four drugs can be reported for each drug abuse episode, there are more mentions than episodes in the data. Individual persons may also be included more than once in the data. Within each facility participating in DAWN, a designated reporter, usually a member of the emergency department or medical records staff, was responsible for identifying drug-related episodes and recording and submitting data on each case. An episode report was submitted for each patient visiting a DAWN emergency department whose presenting problem(s) was/were related to their own drug use. DAWN produces estimates of drug-related emergency department visits for 50 specific drugs, drug categories, or combinations of drugs, including the following: acetaminophen, alcohol in combination with other drugs, alprazolam, amitriptyline, amphetamines, aspirin, cocaine, codeine, diazepam, diphenhydramine, fluoxetine, heroin/morphine, inhalants/solvents/aerosols, LSD, lorazepam, marijuana/hashish, methadone, methamphetamine, and PCP/PCP in combination with other drugs. The use of alcohol alone is not reported. The route of administration and form of drug used (e.g., powder, tablet, liquid) are included for each drug. Data collected for DAWN also include drug use motive and total drug mentions in the episode, as well as race, age, patient disposition, reason for ED visit, and day of the week, quarter, and year of episode.
Curated
Simple Crosstabs
Examining the Multifaceted Impacts of Drug Decriminalization on Public Safety, Law Enforcement, and Prosecutorial Discretion, Oregon, 2008-2024 (ICPSR 39669)
Released/updated on: 2026-03-11
Geographic coverage: Oregon, United States
Time period: 2008-01-01--2024-01-01
This project sought to understand the effects of successive drug policy reforms in the state of Oregon. These include three changes since 2013 to reduce the enforcement and punishment of low-level drug possession. House Bill 3194 passed in 2013, which reduced mandatory minimum sentences for marijuana offenses and diverted more driving and drug-related offenses to probation. House Bill 2355 passed in 2017, which reclassified Schedule I and II possession of controlled substance (PCS), reducing these from a moderate felony to a misdemeanor. Then in 2021, M110 was implemented, downgrading certain quantities of PCS from a misdemeanor to a citation, resulting in a maximum 100 dollar fine or completed health assessment.
The researchers conducted a retrospective longitudinal analysis using statewide administrative data to assess the impacts of these drug law reforms. Measures included police stops, PCS arrests, court filings, convictions, jail and prison admissions, crime rates, drug seizures, and drug-related overdose deaths.
Curated
Oklahoma Methamphetamine Data Initiative, 2018-2022 (ICPSR 38656)
Released/updated on: 2023-12-14
Geographic coverage: United States, Oklahoma
Time period: 2010-01-01--2019-12-31
The Oklahoma Methamphetamine Data Initiative (OMDI) sought to examine the relationship between methamphetamine and violent crime. Both national and local drugs and crime data were collected to inform narcotics law enforcement intervention strategies. OMDI's goals are to establish procedures and metrics to evaluate the relationship between meth and violent crime; identify static and dynamic factors associated with violent crime stemming from meth use or distribution to improve community surveillance in Oklahoma; develop a regularly updated dashboard for law enforcement prevention/intervention deployment; and demonstrate the utility of this model for other states, rural areas, and Indian Country.
Curated
Simple Crosstabs
Wastewater Epidemiology to Examine Stimulant Trends, Kentucky, 2019-2023 (ICPSR 39248)
Released/updated on: 2025-05-29
Geographic coverage: United States, Kentucky
Time period: 2019-01-01--2023-01-01
Wastewater-based epidemiology (WBE) is a scientific approach that allows researchers to monitor population drug exposures by analyzing trace drug residues in untreated wastewater. The Wastewater Epidemiology to Examine Stimulant Trends (WeTEST) project used WBE to develop a wastewater surveillance system at seven traffic rest areas and truck stops along interstate highways passing through Kentucky. This data collection includes one dataset reporting the results of the WeTEST highway surveillance system and four additional datasets reporting trends in stimulant use and related incidents in Kentucky.